Gisbert Schneider is considered a pioneer in the field of targeted molecule design using machine learning methods. The biochemist and bioinformatician has broken new ground and advanced artificial intelligence (AI) to the point that it is now possible to reliably predict the efficacy of drugs. His method builds on the knowledge about known active ingredients, natural products, and their effects, and uses AI to develop new drug candidates with desired properties. Through his excellent research and his unflagging commitment to technology transfer, he was able to gain the trust of industry and thus lay the foundations for the use of these methods in modern biomedical practice. Already today, this technology enables a much more efficient identification of potential active ingredients, thus significantly increasing the chances of success when it comes to the development of new drugs.
Prof. Dr. Gisbert Schneider is Professor of Computer-Assisted Drug Design at the Institute of Pharmaceutical Sciences at ETH Zurich and director of the Singapore-ETH Center. For his outstanding research in the field of molecular design, especially the development of machine learning methods to predict drug activity, Gisbert Schneider receives the Ernst Schering Prize 2022. The transfer of this innovative concept into medicinal chemistry and chemical biology is recognized as an important contribution to the theory and practice of modern biomedicine.
Gisbert Schneider was nominated for the Ernst Schering Prize by the Office of the President of ETH Zurich. The head of the Strategic Foresight Hub at ETH Zurich, Dr. Chris Luebkeman, who will lead a conversation with the awardee about his research at the award ceremony, said: “Drug discovery is a long and laborious process. Gisbert Schneider recognized the potential of machine learning to accelerate the discovery of new medicinal agents and increase selection efficiency. His deep belief in and unwavering commitment to this new approach has led, on a sometimes unpopular path, to a paradigm shift in drug research. I am therefore very pleased that Schneider’s extraordinary achievements will be honored with the Ernst Schering Prize 2022.”
September 30, 2022
Schulfarm Insel Scharfenberg, Berlin-Tegel (not open to the public)
Unter den Linden 32-34
10117 Berlin
Telefon: +49.30.20 62 29 62
Email: info@scheringstiftung.de
Thursday to Monday: 1 pm - 7 pm
Saturday to Sunday: 11 am - 7 pm
free entrance